Antidepressant drugs which are derived from Amphetamine, which are used as a Party drug ecstasy, has found to have anticancer effects. Researchers from the University of Brimingham, in a new study have found that these antidepressant drugs were found to potentially treat Lymphoma.
John Gordon and his team from the University has found that the serotonin receptor was involved in mediating apoptosis in lymphoma cells. These anti-depressant drugs target this receptor on various lymphoma derived B-cell lines.
The drug was found to have significant antiproliferative and pro-apoptotic effects on the tumor cells. "This is quite a breakthrough in medical research into the treatment of lymphoma cancers, including some types of leukemia": said Professor Gordon, "The success of anti-depressant on slowing down the cancer is very exciting."
The doses of these drugs that is required to block cancer growth can be fatal, but further research is required to break down the actions of this designer drug and can extract its cancer killing properties from the more general toxic effects that are associated with its use.